SIHUAN PHARMACE
Research SIHUAN PHARMACE (TEL1) on Bullrun: market cap EUR 848.05M, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTEL1
- ExchangeF
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 848.05M
- Dividend yield2.6%
- Financial periodFY2025
- RevenueEUR 2.62B
- Revenue growth37.7%
- Net incomeEUR 179.70M
- Free cash flow-EUR 218.06M
- Gross margin68.8%
Valuation Snapshot
latest market cap is EUR 848.05M; dividend yield is 2.6%.
About SIHUAN PHARMACE
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.
Frequently asked questions
What is SIHUAN PHARMACE's market cap?
SIHUAN PHARMACE's market capitalization is EUR 848.05M.
Does SIHUAN PHARMACE pay a dividend?
SIHUAN PHARMACE has a dividend yield of 2.6%.
What does SIHUAN PHARMACE do?
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally.